(Q42725797)

5 November 2017

title

Pregabalin and topiramate regulate behavioural and brain gene transcription changes induced by spontaneous cannabinoid withdrawal in mice (English)

1 reference

5 November 2017

0 references

Auxiliadora Aracil-Fernández

series ordinal

1

1 reference

5 November 2017

Pilar Almela

series ordinal

2

1 reference

5 November 2017

Jorge Manzanares

series ordinal

3

1 reference

5 November 2017

publication date

21 October 2011

1 reference

5 November 2017

1 reference

5 November 2017

volume

18

1 reference

5 November 2017

issue

2

1 reference

5 November 2017

page(s)

252-262

1 reference

Role of pregabalin in the treatment of generalized anxiety disorder

5 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Comparing topiramate with naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

The cannabis withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Topiramate attenuates withdrawal signs after chronic intermittent ethanol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Repeated administration with Delta9-tetrahydrocannabinol regulates mu-opioid receptor density in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Mesolimbic dopaminergic decline after cannabinoid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Topiramate (Topamax) reduces conditioned abstinence behaviours and handling-induced convulsions (HIC) after chronic administration of alcohol in Swiss-Webster mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

The cannabinoid CB1 receptor is involved in the anxiolytic, sedative and amnesic actions of benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Nefazodone decreases anxiety during marijuana withdrawal in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Hyperlocomotion and paw tremors are two highly quantifiable signs of SR141716-precipitated withdrawal from delta9-tetrahydrocannabinol in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Pharmacological and biochemical interactions between opioids and cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Efficacy and safety of pregabalin in alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Molecular basis of long-term plasticity underlying addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Plasticity of addiction: a mesolimbic dopamine short-circuit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Spontaneous cannabinoid withdrawal produces a differential time-related responsiveness in cannabinoid CB1 receptor gene expression in the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Pregabalin in the discontinuation of long-term benzodiazepine use: a case-series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

23 Punch sampling biopsy technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Modulation of impulsivity by topiramate: implications for the treatment of alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Effects of topiramate in the treatment of alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

The dopamine hypothesis of reward: past and current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

Anticonvulsant drugs in the treatment of substance withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2011.00406.X

10.1111/J.1369-1600.2011.00406.X

21 January 2018

Identifiers

DOI

1 reference

5 November 2017

1 reference